BIOS Capital Management, LP Long-Term Concentrated

CIK: 0001813845 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 18, 2025

Total Value ($000): $94,099 (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 83.7%

Value ($000) $78,753 Shares 9,893,651 Est. Cost $8.16 Unrealized 0.0%

CGTX COGNITION THERAPEUTICS INC 4.5%

Value ($000) $4,208 Shares 6,000,000 Est. Cost $0.49 Unrealized 0.0%

RNTX AILERON THERAPEUTICS INC 4.1%

Value ($000) $3,889 Shares 1,690,751 Est. Cost $3.03 Unrealized 0.0%

LTRN LANTERN PHARMA INC 4.1%

Value ($000) $3,853 Shares 1,207,709 Est. Cost $3.42 Unrealized 0.0%

— IN8BIO INC 2.4%

Value ($000) $2,212 Shares 8,600,001 Est. Cost $0.26 Unrealized —

IRD OPUS GENETICS INC 1.3%

Value ($000) $1,184 Shares 995,249 Est. Cost $1.15 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	9,893,651	$78,753	83.7%	$8.16	0.0%	COM	005083100
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$4,208	4.5%	$0.49	0.0%	COM	19243B102
RNTX	AILERON THERAPEUTICS INC	1,690,751	$3,889	4.1%	$3.03	0.0%	COM NEW	00887A204
LTRN	LANTERN PHARMA INC	1,207,709	$3,853	4.1%	$3.42	0.0%	COM	51654W101
—	IN8BIO INC	8,600,001	$2,212	2.4%	$0.26	—	COM	45674E109
IRD	OPUS GENETICS INC	995,249	$1,184	1.3%	$1.15	0.0%	COM	67577R102